MOUNTAIN VIEW, Calif., Oct. 4 VIVUS, Inc. (Nasdaq: VVUS) today announced that it has entered into an asset purchase agreement with Meda - an international specialty pharma company - for MUSE®, ...
Meda in deal with two American Companies Meda has signed a long-term license agreement with Vivus for the exclusive marketing rights of MUSE® (alprostadil) in Europe. VIVUS markets MUSE in the US and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results